Noch keine Produkte im Warenkorb.

Ihre Vorteile:

versandkostenfreie Lieferung

i.d.R. sofortige Verfügbarkeit
aller Studien u. Marktanalysen

Bezahlung auf Rechnung
oder per Kreditkarte

Bestell- und Beratungshotline

Gerne helfen wir Ihnen kostenfrei bei der Recherche nach Studien und Marktanalysen:

Tel.: +49 (0)221 168 262 42
E-Mail: service[at]marktforschung.de

Aktuelle Meldungen aus dem Ressort Studien / Marktanalysen:

15.07.10 Kooperation im Vertrieb – wer nicht kooperiert, verliert!

Köln - Wer viel Zeit und Geld hat, der wird in der Wirtschaft alles möglichst alleine machen...


28.06.10 Marktstudie Augenoptik: Die Augenoptikbranche stemmt sich erfolgreich gegen die Wirtschaftskrise

Neuwied - Der deutsche Optikmarkt hat sich zum normalen Konsumgütermarkt entwickelt und seinen...


17.06.10 Marktstudie Elektro-Kleingeräte: Branche im Aufwind

Neuwied - 2009 erreichte der Markt für Elektro-Kleingeräte mit einem Plus von 3,3 Prozent auf 3,4...


Benutzer Anmeldung

Geben Sie Ihren Benutzernamen und Ihr Passwort ein, um sich an der Webseite anzumelden:

Werbung:

Regelmäßig Informationen über neue Studien und Spezialangebote im Shop im kostenlosen E-Mail-Abo.

Mehr Infos? Hier klicken.

Frauenkrankheiten (Gynäkologie)



Studien / Marktanalysen aus der Kategorie Frauenkrankheiten (Gynäkologie)

Titel Veröffentl. Preis netto *

Italy Pharmaceutical Market Overview Generic penetration set to rise

Von: Datamonitor
7 / 2010 7.980,01 €
( 11.400,00 $)

Introduction

The prescription pharmaceutical market in Italy was valued at $24.9 billion in 2009. Key growth drivers for branded pharma include the growing use of chronic high-value innovative treatments driven by a growing elderly population, the high proportion of the healthcare budget spent on pharmaceuticals, and a high level of brand loyalty among Italian patients.

Scope

*Overview of Italy's socioec... more mehr

Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016

Von: GlobalData
5 / 2010 1.400,00 €
( 2.000,00 $)

Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData’s report, 'Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global dysmenorrhea market. The report identifies the key trends shaping and driving the global dysmenorrhea market. The report also provides insight into the prevalent competitive landscape and ... more mehr

Emergency Contraception - Bulgaria

Von: Euromonitor
5 / 2010 675,00 €

Emergency contraception sales in Bulgaria reached BGN1 million in 2009. This growth was driven by Escapelle, a product of the Hungarian company Richter Gedeon Ltd, launched in 2007. The launch was supported by a massive marketing campaign, which included television, radio, billboard and magazine advertisements and various sponsorships. This not only successfully popularised the product but also created consumer awareness of emergency c... more mehr

Emergency Contraception - Iran

Von: Euromonitor
5 / 2010 337,00 €

Emergency contraception recorded value sales of IRR410mn in 2009. It showed current value growth of 55% over the previous year, largely because the product is growing from a small base and retails at a high unit price. It showed good growth as a result of higher demand for this kind of product due to a change in cultural and sexual behaviour of Iranians, particularly the younger generation.

Euromonitor International's Emergen... more mehr

Emergency Contraception - Ukraine

Von: Euromonitor
5 / 2010 675,00 €

In 2009 in value terms the sales of emergency contraception increased by 39% to UAH11 million. Demand for this kind of medicine is not elastic. Moreover, the rising price of condoms (mainly imported) led to a rising number of unplanned pregnancies. Thus the demand for emergency contraception also had a positive rate of growth in 2009.

Euromonitor International's Emergency Contraception Products in Ukraine report offers a comp... more mehr

Women’s Infertility - Drug Pipeline Analysis and Market Forecasts to 2016

Von: GlobalData
4 / 2010 1.400,00 €
( 2.000,00 $)

Women’s Infertility - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist’s new report, 'Women’s Infertility — Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global women’s infertility market. The report identifies the key trends shaping and driving the global women’s Infertility market. The re... more mehr

Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016

Von: GlobalData
4 / 2010 1.400,00 €
( 2.000,00 $)

Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist’s new report, 'Polycystic Ovarian Syndrome— Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global polycystic ovarian syndrome market. The report identifies the key trends shaping and driving the global polycystic ... more mehr

Abnormal Uterine Bleeding Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Abnormal Uterine Bleeding Therapy Area Pipeline Report contains detailed information on the abnormal uterine bleeding drug pipeline. This report provides insight into the pipeline status of abnormal uterine bleeding drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Repo... more mehr

Dysmenorrhea Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Dysmenorrhea Therapy Area Pipeline Report contains detailed information on the dysmenorrhea drug pipeline. This report provides insight into the pipeline status of dysmenorrhea drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail o... more mehr

Endometriosis Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Endometriosis Therapy Area Pipeline Report contains detailed information on the endometriosis drug pipeline. This report provides insight into the pipeline status of endometriosis drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detai... more mehr

Female Sexual Dysfunction Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Female Sexual Dysfunction Therapy Area Pipeline Report contains detailed information on the female sexual dysfunction drug pipeline. This report provides insight into the pipeline status of female sexual dysfunction drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Repo... more mehr

Infertility Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Infertility Therapy Area Pipeline Report contains detailed information on the infertility drug pipeline. This report provides insight into the pipeline status of infertility drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on d... more mehr

Menopausal Symptoms Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Menopausal Symptoms Therapy Area Pipeline Report contains detailed information on the menopausal symptoms drug pipeline. This report provides insight into the pipeline status of menopausal symptoms drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the us... more mehr

Vaginal Infections Therapy Area Pipeline Report

Von: Life Science Analytics
4 / 2010 1.046,50 €
( 1.495,00 $)

Life Science Analytics', Vaginal Infections Therapy Area Pipeline Report contains detailed information on the Vaginal Infections drug pipeline. This report provides insight into the pipeline status of Vaginal Infections drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user ... more mehr

Emergency Contraception - France

Von: Euromonitor
4 / 2010 675,00 €

In 2009, sales of emergency contraception increased by 9% in current value terms, to reach EUR10mn. Demand for emergency contraception remained high, but the 2009 growth rate was lower than 2008. The extensive communication campaign undertaken by the French government and different organisations such as INPES (National Institute for Health Prevention and Education) increased public awareness of STDs (sexually transmitted diseases) and A... more mehr

Emergency Contraception - Spain

Von: Euromonitor
4 / 2010 675,00 €

In 2009 the Spanish Government decided to allow sales of emergency contraception on an OTC basis. However, the fact the there are 17 different regions which are in charge of implementing this new law has resulted in Catañuña being the only region to actual sell these products OTC. Sales of emergency contraception products thus reached a value of just EUR0.8 million in 2009.

Euromonitor International's Emergency ... more mehr

Emergency Contraception - Denmark

Von: Euromonitor
4 / 2010 675,00 €

In 2009, value sales of emergency contraception reached DKr11 million, up 3% in current terms on the previous year. Rising consumer awareness of the products’ existence and greater mistrust of the effectiveness of condoms are driving demand. Consumer trust is a key growth driver, and the longer emergency contraception stays successfully on the market, the more women will begin to trust such products and will use them when they think the... more mehr

Stakeholder Opinions: Sexual Dysfunction - The quest for the new Viagra continues

Von: Datamonitor
3 / 2010 5.320,01 €
( 7.600,00 $)

Introduction

Drug developers interested on the sexual dysfunction market are searching for the next Viagra. Companies are focusing on premature ejaculation and female hypoactive sexual desire disorder, which are suggested to be as prevalent as erectile dysfunction. As products advance through the pipeline, there are several challenges that will have to be addressed in order to succeed in these markets.

Scope
<... more mehr

Endometriosis - Drug Pipeline Analysis and Market Forecasts to 2016

Von: GlobalData
2 / 2010 1.400,00 €
( 2.000,00 $)

Endometriosis - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist's new report, 'Endometriosis - Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global endometriosis market, a key segment within the pharmaceutical and healthcare industry. This pharma report identifies the key trends shaping and drivi... more mehr

Pipeline Insight: Endometriosis - New therapies near market while more innovative targets still needed

Von: Datamonitor
12 / 2009 7.980,01 €
( 11.400,00 $)

Introduction

Endometriosis is a common yet poorly understood gynecological disease that affects women of reproductive age. Symptoms include severe chronic pelvic pain and infertility. Endometriosis affects over 17 million women across the seven major markets. Nonetheless, its complex symptomatology contributes to difficult diagnosis and unclear etiology obstructs the discovery of disease modifying approaches.

Scope... more mehr

Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor types

Von: Datamonitor
9 / 2008 7.980,01 €
( 11.400,00 $)

Introduction

In 2008, the six tumor types covered in this report are forecast to account for over 1.2m new cases of cancer. Collectively, the 36 different drugs in Phase III development for the six tumor types are forecast to achieve $7,049m in sales by 2017. This constitutes a significant proportion of the oncology market, thus representing ample commercial opportunities for drug developers.

Scope

*Exam... more mehr

Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor types

Von: Datamonitor
9 / 2008 7.980,01 €
( 11.400,00 $)

Introduction

In 2008, the six tumor types covered in this report are forecast to account for over 1.2m new cases of cancer. Collectively, the 36 different drugs in Phase III development for the six tumor types are forecast to achieve $7,049m in sales by 2017. This constitutes a significant proportion of the oncology market, thus representing ample commercial opportunities for drug developers.

Scope

*Exam... more mehr

Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand

Von: Datamonitor
6 / 2008 2.660,00 €
( 3.800,00 $)

Introduction

The treatment of menopausal symptoms is a common clinical challenge, with vasomotor symptoms affecting an estimated 75% of women aged over 50 years. Hormone replacement therapy (HRT) has formed the mainstay of treatment for almost 60 years and is highly efficacious. However, concerns surrounding the safety of HRT have led to an increase in demand for non-hormonal alternatives.

Scope

Overview... more mehr

Kidneys and Genito-Urinary System Urinary Incontinence

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Kidneys and Genito-Urinary System Urinary Incontinence ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real d... more mehr

Metabolic Endocrinology Hypogonadism

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Metabolic Endocrinology Hypogonadism ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipe... more mehr

Women's Health Contraception

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Contraception ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, b... more mehr

Women's Health Dysmenorrhea

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Dysmenorrhea ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by... more mehr

Women's Health Endometriosis

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Endometriosis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, b... more mehr

Women's Health Female Sexual Dysfunction

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Female Sexual Dysfunction ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug ... more mehr

Women's Health Infertility

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Infertility ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by ... more mehr

Women's Health Labor and Delivery

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Labor and Delivery ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelin... more mehr

Women's Health Menopausal Symptoms

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Menopausal Symptoms ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipeli... more mehr

Women's Health Postmenopausal Osteoporosis

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Postmenopausal Osteoporosis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on dru... more mehr

Women's Health Vaginal Infections

Von: Life Science Analytics
4 / 2008 1.046,50 €
( 1.495,00 $)

Life Science Analytics', 'Women's Health Vaginal Infections ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelin... more mehr

*Unser Angebot richtet sich an gewerbliche Kunden, daher sind alle Preise netto ausgewiesen.

In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%).

Der korrekte Gesamtendpreis wird Ihnen nach Angabe Ihrer Rechnungsadresse im weiteren Bestellablauf ausgewiesen.